Indeed, oncogenic Kras shapes the immune microenvironment by modulating chemokines, cytokines and growth factors expression with subsequent recruitment of neutrophils and myeloid-derived suppressor cells (MDSCs), creating an immunosuppressive tumor microenvironment [89]. This evidence concerns the gene KRAS and neoplasm.